BioLargo Toekomstige groei
Future criteriumcontroles 2/6
BioLargo is forecast to grow earnings and revenue by 63.3% and 27.2% per annum respectively while EPS is expected to grow by 105.3% per annum.
Belangrijke informatie
63.3%
Groei van de winst
105.3%
Groei van de winst per aandeel
| Chemicals winstgroei | 17.3% |
| Inkomstengroei | 27.2% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 19 Aug 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2025 | 25 | -1 | N/A | N/A | 1 |
| 12/31/2024 | 20 | -3 | N/A | N/A | 1 |
| 6/30/2024 | 17 | -3 | -2 | -1 | N/A |
| 3/31/2024 | 13 | -4 | -3 | -2 | N/A |
| 12/31/2023 | 12 | -4 | -3 | -2 | N/A |
| 9/30/2023 | 10 | -4 | -3 | -2 | N/A |
| 6/30/2023 | 9 | -3 | -3 | -2 | N/A |
| 3/31/2023 | 9 | -3 | -2 | -2 | N/A |
| 12/31/2022 | 6 | -4 | -3 | -3 | N/A |
| 9/30/2022 | 5 | -6 | -4 | -4 | N/A |
| 6/30/2022 | 4 | -7 | -4 | -4 | N/A |
| 3/31/2022 | 3 | -7 | -4 | -4 | N/A |
| 12/31/2021 | 3 | -7 | -4 | -4 | N/A |
| 9/30/2021 | 3 | -6 | -4 | -4 | N/A |
| 6/30/2021 | 3 | -7 | -4 | -4 | N/A |
| 3/31/2021 | 3 | -8 | -4 | -4 | N/A |
| 12/31/2020 | 2 | -8 | -4 | -4 | N/A |
| 9/30/2020 | 2 | -9 | -5 | -5 | N/A |
| 6/30/2020 | 2 | -11 | -5 | -5 | N/A |
| 3/31/2020 | 2 | -10 | -4 | -4 | N/A |
| 12/31/2019 | 2 | -11 | -4 | -4 | N/A |
| 9/30/2019 | 2 | -10 | -4 | -4 | N/A |
| 6/30/2019 | 2 | -9 | -4 | -4 | N/A |
| 3/31/2019 | 1 | -10 | -4 | -4 | N/A |
| 12/31/2018 | 1 | -10 | -4 | -4 | N/A |
| 9/30/2018 | 1 | -10 | -4 | -4 | N/A |
| 6/30/2018 | 1 | -10 | -4 | -4 | N/A |
| 3/31/2018 | 1 | -9 | N/A | -4 | N/A |
| 12/31/2017 | 1 | -9 | N/A | -4 | N/A |
| 9/30/2017 | 0 | -9 | N/A | -4 | N/A |
| 6/30/2017 | 0 | -9 | N/A | -4 | N/A |
| 3/31/2017 | 0 | -9 | N/A | -4 | N/A |
| 12/31/2016 | 0 | -8 | N/A | -4 | N/A |
| 9/30/2016 | 0 | -7 | N/A | -3 | N/A |
| 6/30/2016 | 0 | -6 | N/A | -3 | N/A |
| 3/31/2016 | 0 | -6 | N/A | -3 | N/A |
| 12/31/2015 | 0 | -5 | N/A | -2 | N/A |
| 9/30/2015 | 0 | -5 | N/A | -2 | N/A |
| 6/30/2015 | 0 | -4 | N/A | -2 | N/A |
| 3/31/2015 | 0 | -3 | N/A | -1 | N/A |
| 12/31/2014 | 0 | -4 | N/A | -2 | N/A |
| 9/30/2014 | 0 | -4 | N/A | -2 | N/A |
| 6/30/2014 | 0 | -3 | N/A | -1 | N/A |
| 3/31/2014 | 0 | -3 | N/A | -1 | N/A |
| 12/31/2013 | 0 | -3 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: BLGO is forecast to remain unprofitable over the next 3 years.
Winst versus markt: BLGO is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: BLGO is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: BLGO's revenue (27.2% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: BLGO's revenue (27.2% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if BLGO's Return on Equity is forecast to be high in 3 years time